NEW YORK, Oct. 24 – A limping economy set back Applied Biosystems’ profit by 34 percent in the first quarter while reduced research spending shrank Celera Genomics’ losses in the period, the companies said separately on Wednesday.

However, Celera said it was expecting sales growth of between 40 percent and 50 percent in the new fiscal year, which for it began on Oct. 1, as it signs on new customers for its gene database. Applied Biosystems, meanwhile, has targeted a growth of between 7 percent and 9 percent, Celera said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.